XML 22 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (351,043) $ (4,244)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 58,518 72,547
Goodwill impairments 244,967  
Impairments of definite-lived intangible assets 52,152  
Insurance proceeds received on settlement of claim (14,100)  
Payment on settlement of claim 14,100  
Share-based compensation expense 12,632 15,771
Net provision for doubtful accounts 9,090 5,862
Write-off of debt issuance costs 731  
Amortization of debt issuance costs 3,101 3,703
Write-down on assets held for sale to net realizable value 1,654  
Changes in fair value of contingent consideration 49 2,419
Contingent consideration payments (1,298) (3,181)
Deferred income tax benefit (1,322) (2,034)
Impairment of non-consolidated entities   329
Other (7) (43)
Changes in operating assets and liabilities, net of business acquisition    
Accounts receivable (13,871) (31,090)
Inventories 29,668 36,717
Accounts payable 57,759 (73,227)
Rebates payable 195 1,209
Other assets and liabilities 5,070 8,469
Net cash provided by operating activities 108,045 33,207
Cash flows from investing activities:    
Expenditures for property and equipment (3,961) (7,880)
Expenditures for capitalized software for internal use (14,050) (8,736)
Payments to acquire businesses, net of cash acquired (7,048) (1,139)
Other 22 46
Net cash used in investing activities (25,037) (17,709)
Cash flows from financing activities:    
Net payments on revolving line of credit (71,300) (10,000)
Payments on long term debt (8,625) (82,625)
Payments of debt issuance costs (2,471) (821)
Proceeds from issuance of stock upon stock option exercises 600 3,999
Contingent consideration payments (2,277) (2,088)
Net cash used in financing activities (84,073) (91,535)
Net decrease in cash and equivalents (1,065) (76,037)
Cash and equivalents at beginning of period 9,485 84,251
Cash and equivalents at end of period 8,420 8,214
Supplemental disclosures of cash flow information:    
Cash paid for interest 28,212 27,707
Cash paid for income taxes 2,354 $ 2,142
Noncash investing and financing activities:    
Right-of-use assets obtained in exchange for new operating lease liabilities $ 2,101